Fundraising FoxLYFE Capital — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Molecular Assemblies uses a Fully Enzymatic Synthesis (FES) technology to produce long, pure, and accurate synthetic DNA oligonucleotides, up to 400 bases, without post-synthesis purification.
BiotechDeep TechNew MaterialsSan Diego, US
J. William Efcavitch, Ph.D.(Treasurer and Chief Scientific Officer)Michael J. Kamdar(President, Chief Executive Officer and Secretary)Bill Efcavitch(Founder)Curt Becker(Founder)
BoardDavid Hwang(Director)Larry Stambaugh(Chairman of the Board of Directors)
Co-investors11.2 CapitalDCVC (Data Collective)iSelect FundKeshif VenturesRising TideAlexandria+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.